These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 33252908)

  • 21. Treatments for Parkinson disease--past achievements and current clinical needs.
    Poewe W
    Neurology; 2009 Feb; 72(7 Suppl):S65-73. PubMed ID: 19221317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levodopa-carbidopa intestinal gel therapy after deep brain stimulation.
    Kumar N; Murgai A; Naranian T; Jog M; Fasano A
    Mov Disord; 2018 Feb; 33(2):334-335. PubMed ID: 29105810
    [No Abstract]   [Full Text] [Related]  

  • 23. Central levodopa influx and the clinical motor response to levodopa in patients with Parkinson disease complicated with motor fluctuations and dyskinesias.
    López-Ariztegui N; Arévalo MA; de Ceballos ML; Grandas F
    Clin Neuropharmacol; 2009; 32(6):321-5. PubMed ID: 19667975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Direct switch from conventional levodopa to stalevo (levodopa/carbidopa/entacapone) improves quality of life in Parkinson's disease: results of an open-label clinical study].
    Litvinenko IV; Odinak MM; Mogil'naia VI; Sologub OS; Sakharovskaia AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(1):51-4. PubMed ID: 19156087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis and Management of Parkinson's Disease.
    Tarakad A; Jankovic J
    Semin Neurol; 2017 Apr; 37(2):118-126. PubMed ID: 28511252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Practical approaches to commencing device-assisted therapies for Parkinson disease in Australia.
    Williams DR; Evans AH; Fung VSC; Hayes M; Iansek R; Kimber T; O'Sullivan JD; Sue CM
    Intern Med J; 2017 Oct; 47(10):1107-1113. PubMed ID: 28195385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Continuous dopaminergic stimulation in Parkinson disease: possibilities in 2013].
    Aschermann Z; Kovács N; Komoly S
    Ideggyogy Sz; 2013 May; 66(5-6):209-10. PubMed ID: 23909024
    [No Abstract]   [Full Text] [Related]  

  • 28. [Selection of the optimal device-aided therapy in Parkinson's disease].
    Kovács N; Aschermann Z; Juhász A; Harmat M; Pintér D; Janszky J
    Ideggyogy Sz; 2019 Jan; 72(1-2):5-11. PubMed ID: 30785241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Wearable Sensors for Advanced Therapy Referral in Parkinson's Disease.
    Heldman DA; Giuffrida JP; Cubo E
    J Parkinsons Dis; 2016 Jul; 6(3):631-8. PubMed ID: 27392872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The nurse's role in clinical trials.
    Amyot D; Gray P; Demong C; Wilson W; Murphy D; Watson J; Duff J
    Can Nurse; 1996 Nov; 92(10):30-2. PubMed ID: 9095759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of advanced Parkinson's disease.
    Diamond A; Jankovic J
    Expert Rev Neurother; 2006 Aug; 6(8):1181-97. PubMed ID: 16893346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized trial of pallidotomy versus medical therapy for Parkinson's disease.
    Vitek JL; Bakay RA; Freeman A; Evatt M; Green J; McDonald W; Haber M; Barnhart H; Wahlay N; Triche S; Mewes K; Chockkan V; Zhang JY; DeLong MR
    Ann Neurol; 2003 May; 53(5):558-69. PubMed ID: 12730989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Managing the patient with newly diagnosed Parkinson disease.
    Singer C
    Cleve Clin J Med; 2012 Jul; 79 Suppl 2():S3-7. PubMed ID: 22761267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comprehensive approach to Parkinson's disease. How to manage fluctuating motor and nonmotor symptoms.
    Brunton S
    Postgrad Med; 2006; 119(1):55-64. PubMed ID: 16913648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review.
    Wirdefeldt K; Odin P; Nyholm D
    CNS Drugs; 2016 May; 30(5):381-404. PubMed ID: 27138916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment possibilities in advanced Parkinson's disease].
    Takáts A; Nagy H; Radics P; Tóth A; Tamás G
    Ideggyogy Sz; 2013 Nov; 66(11-12):365-71. PubMed ID: 24555235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in levodopa therapy for Parkinson disease: Review of RYTARY (carbidopa and levodopa) clinical efficacy and safety.
    Dhall R; Kreitzman DL
    Neurology; 2016 Apr; 86(14 Suppl 1):S13-24. PubMed ID: 27044646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. International Parkinson and movement disorder society evidence-based medicine review: Update on treatments for the motor symptoms of Parkinson's disease.
    Fox SH; Katzenschlager R; Lim SY; Barton B; de Bie RMA; Seppi K; Coelho M; Sampaio C;
    Mov Disord; 2018 Aug; 33(8):1248-1266. PubMed ID: 29570866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.
    Parkinson Study Group
    JAMA; 2000 Oct; 284(15):1931-8. PubMed ID: 11035889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson's disease: a multi-country Delphi-panel approach.
    Antonini A; Stoessl AJ; Kleinman LS; Skalicky AM; Marshall TS; Sail KR; Onuk K; Odin PLA
    Curr Med Res Opin; 2018 Dec; 34(12):2063-2073. PubMed ID: 30016901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.